Phase 2 Myeloma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are willing to be informed about the trial and sign a consent form agreeing to take part voluntarily.
- You are 18 years of age or older.
- You have been diagnosed with multiple myeloma (a type of blood cancer) using standard international diagnostic guidelines.
- You have experienced a reaction called CRS (cytokine release syndrome) and/or a brain-related side effect called ICANS after receiving CAR-T cell therapy (a type of immune cell treatment).
Who may not be able to join:
- Your kidneys are not filtering blood well enough (low kidney function, confirm with trial site).
- Your blood counts are too low at the time of screening — this includes low platelets (which help blood clot), low white blood cells (which fight infection), or low red blood cells (which carry oxygen).
- Your liver is not working well enough, based on blood test results showing certain liver-related levels are too high.
- You have serious heart problems, such as severe heart failure, uncontrolled chest pain, irregular heartbeat, very high blood pressure, a heart attack within the last 6 months, or a prior stroke that has left lasting effects.
- You have certain other serious health conditions, including active infections, active hepatitis B or C, HIV, uncontrolled diabetes, severe lung disease, or significant liver scarring (cirrhosis).
- You are known to have a bad reaction or allergy to the drug Siltuximab.
- The cancer has spread to your brain or spinal cord (central nervous system involvement).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 86-022-23909171
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Complete CRS resolution rate
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.